Prefilled syringes are disposable syringes, filled with a fixed quantity of therapeutic drug. The syringes are designed to administer the accurate amount of dosage for reducing the wastage of medication. These are novel devices used for delivering drugs with improved affordability, accuracy, efficacy, convenience, safety, sterility, and accessibility. The syringes are used in treatment of diabetes, anaphylaxis, rheumatoid arthritis, and other diseases, such as multiple sclerosis, psoriasis and anemia.
According to study, “Global Prefilled syringes Market Size study, by material (glass-based and plastic based) type (safety prefilled syringes and conventional prefilled syringes) Design (single-chamber prefilled syringes, dual-chamber prefilled syringes and customized prefilled syringes) and Regional Forecasts 2018-2025” the key companies operating in the global prefilled syringes market are Gerresheimer AG, Becton, Dickinson and Company, Abbott Laboratories, Schott AG, Terumo Medical Corporation, Cardinal Health, Inc., Scandinavian Health Limited (SHL Group), Unilife Corporation, Vetter Pharma International GmbH, West Pharmaceutical Services, Inc., Baxter International, Catalent, Inc., Stevanato Group, Weigao Group, Nipro Corporation, OMPI, Medpro Inc.
Based on type, prefilled syringes market is segmented into safety prefilled syringes and conventional prefilled syringes. Based on material, market is segmented into plastic syringes and glass prefilled syringes (baked on silicone syringes and oil siliconised syringes). Plastic prefilled syringes holds major share in market owing to increase in awareness among healthcare practitioners and physicians to decrease medication errors. Based on design type, market is segmented into single-chamber prefilled syringes, dual-chamber prefilled syringes and customized prefilled syringes. Single-chamber prefilled syringes segment provides safety and simplifies needle stick protection. Based on therapeutic, market is segmented into small molecules and large molecules. Based on application, market is segmented into rheumatoid arthritis, anaphylaxis, diabetes, and others (multiple sclerosis, cancer, and others). In addition, based on end-user, market is segmented into ambulatory surgical center, mail order pharmacies and hospitals or clinics.
The prefilled syringes market is driven by rise in incidence rate of chronic disease, followed by growth in home-based healthcare market, increase in adoption of self-injection devices such as pen injectors, growth in technological advancement, appropriate reimbursement policies, increase in advancement in biopharmaceutical industry, rise in demand for efficient & easy-to-use drug delivery devices and increase in benefits of using prefilled syringes over conventional vials. However, stringent government regulations, product recalls and availability of alternate drug-delivery methods may impact the market. Moreover, increase in demand for injectable drugs in prefilled forms and rise in demand for biologics & bio-similars are key opportunities for market. Furthermore, rise in adoption of ready-to-use elastomeric & customized syringe components by drug manufacturers is major trend of market.
Based on geography, the North-American and European regions hold major share in prefilled syringe market owing to constant increase in geriatric population, rise in trend of home-based treatment as well as high healthcare expenditure and increase in demand for quality healthcare in the regions. The Asian-Pacific region is expected to emerge as the fastest growing region due to increase in number of clinics & hospitals and improvement in healthcare infrastructure over the forecast period. It is anticipated that the market will be reached at US $9.3 billion by 2025.
For more information, click on the link below:
Global Prefilled syringes Market
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91 9015378249
